Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 33.04% is 26% above its 5-year average of 26.18%, around the middle of its 5-year range (0.00%–100.00%).
33.86% below its 12-month average of 49.95%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
33.04%
GROSS MARGIN AVG TTM
49.95%
GROSS MARGIN AVG 3Y
34.60%
GROSS MARGIN AVG 5Y
26.18%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-33.86%
CURRENT VS 3Y AVG
-4.50%
CURRENT VS 5Y AVG
+26.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.38%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-18.18%
vs the sector median at left
Market Cap
$97.81M
Gross Margin
94.58%
TTM Avg
46.31%
3Y Avg
73.16%
5Y Avg
65.44%
Market Cap
$96.58M
Gross Margin
10.89%
TTM Avg
14.00%
3Y Avg
13.41%
5Y Avg
13.41%
Market Cap
$94.01M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$103.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$103.60M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
5.83%
5Y Avg
8.02%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $98.69M | 33.04% | 49.95% | 34.60% | 26.18% |
| PolyPid Ltd. (PYPD)vs › | $98.56M | 0.00% | 0.00% | 0.00% | 0.00% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.81M | 94.58% | 46.31% | 73.16% | 65.44% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | 10.89% | 14.00% | 13.41% | 13.41% |
| The Joint Corp. (JYNT)vs › | $103.21M | 81.08% | 78.73% | 81.53% | 84.24% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $94.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Conexeu Sciences Inc. (CNXU)vs › | $97.67M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.60M | 0.00% | 0.00% | 5.83% | 8.02% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.27M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
33.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 49.77% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 33.10% |
